Administration of either tumour necrosis factor alpha or 16,16-dimethylprostaglandin E2 (PGE2) to female NMRI mice caused a decrease in body weight accompanied by a reduction in both food and water intake and a decrease in carcass water content. A single injection of TNF-2 caused an enhanced production of PGE2 by spleen cells from treated animals, that was significant within I h of treatment, and persisted until at least 6h. These results suggest that the anorectic effect of TNF-z may be mediated by a prostaglandin intermediate. Indomethacin (lOmgkg-) administered 2h before TNF-a (7.5 x 107 U kg-') caused a significant reduction in the extent of weight loss and inhibited PgE2 production. Administration of indomethacin 0.5-1.5 h before the TNF-z had no significant effect on loss of body weight, but still inhibited PgE2 production. Also PgE2 production was still enhanced in response to TNF-2 administered chronically, despite the inability of prolonged TNF-z administration to produce continued loss of body weight. These results suggest that prostaglandins are not involved in the anorectic effect of TNF-z.
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The catabolic states associated with infection or endotoxemia have been attributed to the production by phagocytic cells of soluble proteins such as interleukin 1 and cachectin (Rouzer & Cerami, 1980; Moldawer et al., 1987a; Cerami et al., 1985) . A high degree of homology has been shown to exist between the N-terminal sequence of mouse cachectin and the N-terminal sequence for human tumour necrosis factor-alpha (TNF-x) and the catabolic states have been extended to include also cancer-associated cachexia (Beutler & Cerami, 1986) . Severe weight loss and increased mortality have been observed in mice bearing transgenic tumours that persistently secrete human cachectin (Oliff et al., 1987) and chronic administration of sublethal doses of TNF-x to rats caused anorexia, weight loss, depletion of body lipid and protein, a reduction of red blood cell mass, leukocytosis and tissue inflammation (Tracey et al., 1988) . However, in a number of studies (Stovroff et al., 1988; ) administration of TNF-x caused a loss in body weight accompanied by a drop in food and water intake, which was only apparent over the first 24h, after which animals became resistant to subsequent dosing. In addition TNF-x has not been detectable in the serum of patients with clinical cancer cachexia (Socher et al., 1988) and in clinical tnrals of recombinant human TNF-x there was no clinical evidence of accelerated cachexia, although anorexia was present during administration (Sherman et al., 1988) . Also the effects on host metabolism produced by TNF-:x appear to differ from that produced by a cachexiainducing tumour .
The toxic and metabolic effects of TNF-:z can be blocked by a single injection of the cyclo-oxygenase inhibitors indomethacin or ibuprofen before the TNF-x treatment (Kettlehut et al., 1987) . This suggests that some of the effects of TNF-x may be mediated through a prostaglandin intermediate in analogy with septic shock where large inacreases in circulatory prostaglandins have been reported in a variety of experimental models (Cook et al., 1980) . In order to study the role of prostaglandins in the mechanism of weight loss induced by TNF-r we have used NMRI mice, a strain we have utilised to passage a colon adenocarcinoma which induces cachexia in recipient animals .c The Macmifan Press Ltd., 1989 PgE2 anal'sis Male NMRI mice (20-26 g) were injected i.v. with 7.5 x 107 U kg-TNF-7 or 0.9% NaCI. At specified time points after injection animals were killed by cervical dislocation and the spleens rapidly removed and weighed.
Spleens were sliced on filter paper moistened with cold 0.85% NaCI and then placed in a 25 ml flask containing 2 ml of Krebs-Ringer bicarbonate medium containing 1nmgnml-' each of glucose and bovine serum albumin. The slices were first incubated at 37-C for 20min in a gas phase of 5% CO2/95% N2 and then transferred to flasks containing 5% Co2 /95% 02 for a further 15 min. At the end of the incubation spleens were removed and the medium was immediately frozen at -96°C and only defrosted immediately before extraction.
For the determination of PgE2 1 ml of thawed medium was removed, adjusted to pH 3 to 3.5 with 2N HC1 and extracted twice with 3 ml of ethyl acetate. The extract was evaporated to dryness under a stream of nitrogen and dissolved in 0.025 M phosphate buffer, pH 6.8. containing 0.01 M EDTA, 0.9% NaCI, 0.3% bovine y-globulin, 0.005% triton x 100 and 0.05% sodium azide and the concentration of PgE2 was determined using a radioimmunoassay (NEN, Dreieich, FR Germany).
Statistical analysis
All results were analysed statistically using the analysis of vanance or F ratio.
Results
We have utilised PgE2 production by spleen cells rapidly removed from TNF-x treated animals as an indirect method of measuring prostaglandin production because of difficulties in measuring plasma levels of PgE2 directly. The radioimmunoassay utilised for these measurements had not previously been tested on mouse plasma and our investigations revealed an inhibition of the binding of PgE2 from mouse plasma with the antibody used in the assay. The results presented in Figure show an enhanced production of PgE2 by spleen cells after administration of TNF-r (7.5x 10 U kg-1), which was significantly greater than saline infused controls within I h after administration, and remained elevated up to 6 h after treatment. This suggests that some of the metabolic effects of TNF-x may be mediated via prostaglandin production. Administration of TNF-x (7.5x 107Ukg-') produced a decrease in body weight within the first 24h after administration (Figure 2a ), accompanied by a decrease in food and water intake (Figure 2b ). Body composition analysis revealed a decrease in the body water content of TNF-x treated mice, when compared with saline infused controls (Figure 2c) (Figure 2a ) which was similar to that produced by TNF-a in that it was accompanied by a reduction in both food and water intake ( Figure 2b ) and a decrease in the body water content (Figure (Figure 3) . This difference was not explained by decreased excretion of urine (Table II) . Animals treated with TNF-xz had a significant reduction in the excretion of both urine and faeces, indicating that the decrease in body water content did not arise from a diuretic effect of TNF-ox. 16,16-Dimethyl PgE2 also caused a reduction in urine and faeces production (Table II) . Indomethacin had no effect on urine or faeces production in control animals, although there was a small increase in faeces production in TNF-2 treated animals.
The effect of indomethacin on PgE2 production by spleen cells from TNF-x treated animals is shown in Table I . All values were measured 2h after TNF-:x administration since PgE2 production in response to TNF-x was significantly elevated at this point (Figure 1 ). Indomethacin inhibited PgE2 production in response to PgE2 irrespective of the time of administration with respect to TNF-x, although the reversal of body weight loss was highly dependent on the time of administration (Table I ). This suggests that indomethacin did not reverse the TNF-z induced weight loss as a result of inhibition of prostaglandin synthesis and that prostaglandin production was not necessary for weight loss to occur.
This conclusion was also substantiated by measurement of PgE2 production by spleen cells when TNF-xz was administered chronically. As previously reported , animals become resistant to subsequent injections of TNF-:x after the first 24h with the body weight increasing towards that of controls. At 24h PgE2 production by spleen cells was 0.51 + 0.04 ng mg1 wet weight in controls and 1.98+0.16ngmg'-wet weight in TNF-2 treated animals, i.e. 3.9 times the control value. This difference was maintained up to 5 days of TNF-:x administration (3.7 times the control value) despite the fact that the animals were gaining weight. This suggests that PgE2 production is not involved in the weight loss produced by TNF-x.
Discusio
There is some evidence to suggest that prostaglandins may be involved in the metabolic effects of TNF-x. An increase in plasma prostaglandin levels has been observed within 1 h of TNF-:x administration accompanied by a sharp fall in body temperature and blood glucose levels (Kettlehut et al., 1987) . Inhibition of prostaglandin production prevented the hypothermia and changes in blood glucose. Production of PgE2 is also enhanced after stimulation of mouse osteoblastlike cells (Sato et al., 1987) and endothelial cells (Dayer et al., 1985) with TNF-x. Both TNF-x and interleukin I have been shown to stimulate the production of PgE2 by isolated extensor digitorum longus muscles (Moldawer et al., 1987a Indomethacin administration decreases both the weight loss and dehydration after TNF-:x, suggesting that the anorectic effect is mediated through a prostaglandin intermediate. However, Marquet et a] . (1987) showed that, although indomethacin administered before murine TNF-x alleviated the toxic side effects in rats, it had no effect on the excessive wasting produced by high doses of TNF-xz. The reason for this disparity is not immediately clear, but could be related to differences between murine and human TNF-:x, or to the timing of the indomethacin administration, which in our case required a period of 2 h between indomethacin and TNF-x.
Despite this stringent time requirement for reversal of weight loss, indomethacin was equally effective in inhibiting PgE2 production after TNF-x administration at all times from 0.5 to 2 h before TNF-:x. These results suggest that prostaglandins are not involved in the weight loss induced by TNF-x. This is further confirmed by measurement of PgE2 production after chronic administration of TNF-x, when the animals become resistant to subsequent injections of TNF-:x after the first 24h . The nature of this tachyphylaxis is not understood at present, but can be overcome by increasing dosage to maintain a constant food intake (Tracey et al., 1988) . Despite the inability of repeated treatment of TNF-a to produce continued weight loss it appeared to be equally effective in stimulating spleen PgE2 production up to 5 days of treatment. This again confirms that prostaglandins are not involved in the anorectic effect of TNF-x. Intracerebroventricular microinfusion of TNF-x has been shown to supress food intake in rats (Plata-Salaman et al., 1988) , possibly by inhibiting glucose-sensitive neurons in the lateral hypothalamic area, and this effect alone may be responsible for the anorexia and weight loss induced by TNF-x. Cyclooxygenase inhibitors have been shown to decrease sodium and water excretion in both man (Haylor, 1980) and the rat (Haylor & Lote, 1980) , resulting in retention of body fluid. In the present experiments indomethacin had no effect on urine or faeces production either alone or in the presence of TNF-x, nor did it cause appreciable fluid retention above saline infused controls. It did, however, reverse the decrease in body water content caused by TNF-x and also reversed to some extent the weight loss. The mechanism of this effect is currently under investigation.
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